The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the third quarter.

Beacon Software, a holding company that acquires smaller software businesses and ...

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings this Wednesday afternoon. Here’s what to ...

Novo Nordisk's new CEO, Mike Doustdar, is under significant pressure as the company contends with declining stock prices, ...

LONDON (Reuters) -Novo Nordisk’s new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its ...

Plus, inside the super secretive intelligence firm Black Cube and Pfizer takes no prisoners in its fight to buy Metsera ...

Animal health company Elanco (NYSE:ELAN) will be reporting earnings this Wednesday before market hours. Here’s what investors ...

Novo Nordisk is confident its bid for U.S. drugmaker Metsera doesn't raise antitrust issues. The $8.5 billion offer tops ...

Pfizer beat analysts’ revenue expectations by 7.9% last quarter, reporting revenues of $14.65 billion, up 10.3% year on year.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

The support is broad to encourage institutions to consider how to address AI-related challenges and opportunities in ways ...

Duvakitug outperformed placebo at week 14 in endoscopic response and was well tolerated among patients with moderately to severely active Crohn’s disease, according to research presented at ACG Annual ...